title: [Palmar fasciitis after carboplatin administration for an ovarian adenocarcinoma].
authors.forename: Y
authors.initials: Y
authors.lastname: Ollivier
authors.forename: C
authors.initials: C
authors.lastname: Andrès
authors.forename: A L
authors.initials: AL
authors.lastname: Laplaud
authors.forename: E
authors.initials: E
authors.lastname: Sevin
authors.forename: P
authors.initials: P
authors.lastname: Letellier
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018283:Cystadenocarcinoma, Papillary / Q000150:complications / Q000188:drug therapy*; D005208:Fasciitis / Q000139:chemically induced / Q000209:etiology*; D005260:Female; D006225:Hand; D006801:Humans; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D010257:Paraneoplastic Syndromes; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D016190:Carboplatin; D011241:Prednisone